psychedelics investing Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
psychedelics investing Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
Psychedelics Investing Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
Psychedelics Investing Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Psychedelics Investing Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Psychedelics Investing Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
Bold Ventures Announces Increase and Extension of Non-Brokered Private Placement and Closing of Third Tranche, and Signs Agreement with Investor News Network
Finlay Minerals Announces Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
Ramp Metals Announces Closing of Oversubscribed Non-Brokered Private Placement for Proceeds of Approximately $3.425M
